Stay updated on AK002 Safety, PK, PD in Healthy Participants Clinical Trial
Sign up to get notified when there's something new on the AK002 Safety, PK, PD in Healthy Participants Clinical Trial page.

Latest updates to the AK002 Safety, PK, PD in Healthy Participants Clinical Trial page
- Check2 days agoChange DetectedThe page now presents the record for a completed Phase 1 study evaluating the safety and pharmacology of AK002 in healthy participants. It includes the study design, participant criteria, outcome measures, and record dates.SummaryDifference40%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The study record remains inaccessible and displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner appears above the ClinicalTrials.gov page announcing an NIH website transition and explaining that both “Super Intelligence” and “Artificial Intelligence” terminology may appear during the transition.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedAccess to the study page now renders a 403 Forbidden error page with a standard HTML header and message, replacing the previously visible study details. This indicates the page is blocked or unavailable, affecting the ability to view the trial information.SummaryDifference17%

Stay in the know with updates to AK002 Safety, PK, PD in Healthy Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 Safety, PK, PD in Healthy Participants Clinical Trial page.